Youngil Sitagliptin Tablet 25 mg (Sitagliptin Hydrochloride Hydrate)
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.
MFDS item code 202005309 · Approved 2020.07.23
This product's status changed to Expired on 2025.07.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapies, and if blood sugar control is difficult, it can be used in conjunction with other diabetes medications. For example, it is effective in controlling blood sugar when administered with metformin, sulfonylureas, thiazolidinediones, or insulin. This medication helps increase blood sugar improvement effects among various treatment methods. Therefore, it is used to improve blood sugar control in patients with type 2 diabetes.
This medicine is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function before starting this medicine and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered without regard to the timing of dialysis.
This medication is used to treat diabetes and helps control blood sugar levels. While taking this medication, serious allergic reactions may occur rarely, so if you experience symptoms such as skin rash, difficulty breathing, or swelling of the face or neck, you should seek medical attention immediately. Additionally, serious side effects such as pancreatitis, which is inflammation of the pancreas, have been reported, so if you experience symptoms like abdominal pain, nausea, or vomiting, you should stop taking the medication immediately and consult a doctor. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor should it be taken by those who are allergic to this medication or its ingredients. Patients with impaired kidney function may need dosage adjustments, so regular kidney function tests are recommended, and it should be taken under the direction of a physician. This medication can be used alone or in combination with other diabetes treatments; however, when taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so it is important to closely monitor blood sugar levels. Symptoms of hypoglycemia include dizziness, trembling, and cold sweat, and appropriate measures should be taken immediately if these symptoms occur. Use during pregnancy or breastfeeding is not recommended, and the safety and efficacy have not been established for children and adolescents under 18 years of age. For the elderly, dosage adjustments and kidney function tests may be necessary due to the possibility of decreased kidney function. In cases of overdose, gastrointestinal decontamination may be needed, and monitoring through an ECG or other tests should be done, and blood dialysis may be helpful if necessary. This medication has been reported to cause side effects such as joint pain or skin disorders in some patients; therefore, if symptoms are severe, consultation with a doctor is advisable. Finally, while this medication does not have significant interactions with many other drugs, it may cause changes in blood concentration when used in conjunction with certain medications, so patients should inform their doctor of any medications they are currently taking.
Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, upper respiratory tract infection, nasopharyngitis, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, severe joint pain accompanied by disability, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, elevation of liver enzymes, acute renal failure, pneumonia, diabetes complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased blood triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air from entering and kept at room temperature between 1°C and 30°C. Following this storage method helps maintain the medication's efficacy for a longer period.
Light orange, round, biconvex film-coated tablets.
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Korea United Pharm., Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 128.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Sitagliptin Hydrochloride Hydrate 28.35mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 56.7mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Sitagliptin Hydrochloride Hydrate 113.4mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.